MedTrace Logo

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

NCT00147836 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 436

Last updated 2008-04-01

No results posted yet for this study

Summary

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemic agents) on glycemic control, B-cell function and the remission rate in newly-diagnosed type 2 diabetic patients.

Conditions

Interventions

DRUG

Human Insulin (Novolin-R, Novo Nordisk)

DEVICE

H-Tron Plus V100; Disetronic Medical System, Burgdorf, Switzerland

OTHER

Pre-meal

DRUG

Novolin-R

DRUG

Human Insulin NPH (Novolin-N, Novo Nordisk)

DRUG

Gliclazide (Diamicron, Servier)

DRUG

Diamicron and Glucophage

Sponsors & Collaborators

  • Ministry of Education, China

    collaborator OTHER_GOV

  • Guangdong Science and Technology Bureau, China

    collaborator UNKNOWN

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Jianping Weng, MD,PHD · Ministry of Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00147836 on ClinicalTrials.gov